Physician profile
Richard E Toran
NPI 1073552071
$13,551.00
in general payments reported to CMS, 2019-2025
10 companies · $3,150 in 2025
The $3,150 reported for 2025 was more than what 81% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2021: $260 · 2022: $3,310 · 2023: $3,581 · 2024: $1,613 · 2025: $3,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,991 · Travel and Lodging: $3,664 · Consulting Fee: $673 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,991.24 |
| Travel and Lodging | $3,664.44 |
| Consulting Fee | $672.75 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $4,465.68 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $3,103.64 | 2019-2025 | Intracept, General - Pain Management, Eluvia |
| Genesys Orthopedics Systems, L.L.C. | $2,121.78 | 2023 | Sacroiliac Joint Fusion System |
| Medtronic, INC. | $1,898.00 | 2021-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $1,364.86 | 2019 | |
| Stryker Corporation | $257.70 | 2024 | Spinejack, Optablate |
| Si-Bone, INC. | $170.65 | 2025 | |
| Abbott Laboratories | $103.15 | 2024 | Eterna |
| Moximed, INC | $37.27 | 2025 | Misha Knee System, Small, Left |
| W. L. Gore & Associates, INC. | $28.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Toran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.